π Cell Reports 45:118292 (Nov 24, 2026) β open access
π https://doi.org/10.1016/j.celrep.2026.118292
Background:
CD8 T cell responses are organized into immunodominance hierarchies, so a SARS-CoV-2 spike mutation that hits a dominant epitope can have outsized consequences. We previously showed that the spike L452R mutation allows escape from HLA-A*24:02-restricted CD8 T cells specific for the immunodominant NF9 epitope (S448β456: NYNYLYRLF)[1][2], and that the underlying mechanism is a position-5-driven reorientation of the peptide that remodels the TCR-exposed surface and abolishes recognition by public TCRs [3]. What remained unclear was whether the escape variant itself (NF9-5R) primes a new, variant-specific CD8 T cell response that could fill the gap. Here we addressed this question in Omicron BA.5 convalescents and HLA-A24 transgenic mice, combined with in vitro priming and single-cell TCR cloning and TCR reconstruction.
Highlights:
β NF9-5R-specific CD8 T cells were not detected in BA.5 convalescents β neither ex vivo nor after short-term in vitro stimulation β despite robust responses to other epitopes.
β In HLA-A24 transgenic mice, NF9 was markedly more immunogenic than NF9-5R, with only minimal cross-reactivity between the two.
β In vitro priming of convalescent PBMCs identified a rare cross-reactive TCR (12E) recognizing both NF9 and NF9-5R.
β TCR 12E recognized spike L452R-expressing cells, showing that NF9-5R is presented by HLA-A24 β so the missing response reflects a repertoire-level blind spot, not a failure of antigen presentation.
Summary:
When a T cell epitope mutates, the immune system does not necessarily fill the gap β it can be left with a blind spot. This has direct implications for how variant-adapted vaccines should be designed.
Special thanks to Prof. Andrew Sewell and Dr. Aaron Wall (Cardiff University) for the great long-standing collaboration π!
Many congrats to all co-authors, especially the first author, my Ph.D. student, Huanyu Li (Kumamoto University) π.
References:
1. Motozono C, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe, 29:1124β1136.e11 (2021). doi:10.1016/j.chom.2021.06.006
2. Motozono C, et al. The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition. Nat Commun, 13:5440 (2022). doi:10.1038/s41467-022-33068-4
3. Nakama T, et al. Position-5-driven reorientation of an immunodominant HLA-A*24:02 SARS-CoV-2 epitope drives universal T cell escape. JCI Insight, 11:e202235 (2026). doi:10.1172/jci.insight.202235